ASCO 2025 will feature the latest advancements in genitourinary cancer and melanoma treatment, focusing on the exciting developments in immunotherapy. Stay updated on the cutting-edge research and ...

For the second year running, data at ASCO on Merus' bispecific antibody petosemtamab in head and neck cancer has drawn the eye, as the company talks up its potential to become a new standard of care.

Alcohol drinking is an established risk factor for several malignancies, and it is a potentially modifiable risk factor for cancer. The Cancer Prevention Committee of the American Society of Clinical ...

Meeting Abstract: 2020 ASCO Annual Meeting I. Free access. Breast Cancer—Metastatic. May 25, 2020. Share on. KEYNOTE-355: Randomized, double-blind, phase III study of pembrolizumab + chemotherapy ...

ASCO: American Society of Clinical Oncology. home / conference / asco. CARTITUDE-4 Data Solidify Cilta-cel’s Role in RRMM: Surbhi Sidana, MD, MBBS. Maggie L. Shaw; Surbhi Sidana, MD, MBBS.

At ASCO 2025, CCM Biosciences’ presentation “Novel, potent and selective fourth-generation inhibitors targeting EGFR for NSCLC therapy” in the Lung Cancer – Non-small cell – Metastatic ...

Merck, a leading science and technology company, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 American Society of Clinical Oncology (ASCO ...

Written by: Julian Chavarriaga, MD – Urologic Oncologist at Cancer Treatment and Research Center (CTIC) via Society of Urologic Oncology (SUO) Fellow at The University of Toronto. @chavarriagaj on ...

Written by: Julian Chavarriaga, MD – Urologic Oncologist at Cancer Treatment and Research Center (CTIC) via Society of Urologic Oncology (SUO) Fellow at The University of Toronto. @chavarriagaj on ...